Building the Experimental Intelligence Engine for AI-Native Protein Biology
Neomera BioLab is a platform biotechnology company developing proprietary interaction data systems for next-generation biologics and peptide therapeutics.
By integrating advanced experimental biology with machine learning, Neomera creates high-value biological intelligence around complex therapeutic targets and applies it to a focused internal pipeline.
Better AI Model Starts with Better Data
AI drug discovery is only as good as the biological data it learns from. Neomera generates proprietary, high-resolution interaction datasets that capture the complexity of biology — providing the ground truth needed to train models, de-risk programs, and discover transformative therapeutics.
Proprietary Interaction Intelligence
We interrogate challenging biological systems with depth and precision to map meaningful protein interactions.
Our data reflects native biology, functional context, and the nuances that drive therapeutic outcomes.
Purpose-built datasets power machine learning models that uncover biology and guide confident decisions.
Internal Therapeutics Powered by the Platform
NaV1.7 / 1.8 / 1.9 Oral Peptide Inhibitor
Selective GPCR Inhibitor
Target Discovery Program
Strategic Partnerships
Neomera engages selectively with biopharma and AI-native discovery partners to advance breakthrough biology and create meaningful impact for patients.
Partner With Us →